V. 
References 
1 . Boring, C.C., T.S. Squires, and T. Tong, Cancer Statistics. CA, Cancer J. Clinicians, 1993. 43: p. 
7-26. 
2. Burger, P.C., B.W. Scheithauer, and F.S. Vogel, Surgical pathology of the nervous system and its 
coverings. 3rd ed. 1991, New York, NY: Churchill Livingston. 
3. Burger, P.C., E.R. Heinz, and T. Shibata, Topographic anatomy and CT correlations in the 
untreated glioblastoma multiforme. J. Neurosurgery, 1988. 68: p. 698-704. 
4. Hochberg, F.H. and A. Pruitt, Assumptions in the radiotherapy of glioblastoma. Neurolog, 1980. 
30: p. 907-911. 
5. Mahaley, M.S.J., et al., National survey of patterns of care for brain-tumor patients. J. 
Neurosurg., 1989. 71: p. 826-836. 
6. Curran, W.J.J., et al., Recurse partitioning analysis of prognostic factors in three radiation 
therapy oncology group malignant glioma trials. J. Nat'l. Cancer Inst., 1993. 85: p. 704-710. 
7. Leibel, S.A., C.B. Scott, and J.S. Loeffler, Contemporary approaches to the treatment of malignant 
gliomas with radiation therapy. Sem. Oncol., 1994. 21: p. 198-219. 
8. Scharfen, C.O., et al., High activity 1-125 interstitial implant for gliomas. Int. J. Radiat. Oncol. 
Biol. Phys., 1992. 24: p. 583-591. 
9. Walker, M.D., et al., Randomized comparisons of radiotherapy and nitrosoureas for the treatment 
of malignant glioma after surgery. New Eng. J. Med., 1980. 303: p. 1323-1329. 
10. Kornblith, P.L. and M. Walker, Chemotherapy for malignant gliomas. J. Neurosurg., 1988. 68: 
p. 1-17. 
11. Yung, W.K., et al., Intravenous recombinant interferon beta in patients with recurrent 
malignant gliomas: a phase I/ll study. J. Clin. Oncol., 1992. 9(11): p. 1945-9. 
12. Merchant, R.E., et al., Intralesional infusion of lymphokine-activated killer (LAK) cells and 
recombinant interleukin-2 (rlL-2) for the treatment of patients with malignant brain tumor. 
Neurosurgery, 1988. 23(6): p. 725-32. 
13. Jaekle, K.A., Immunotherapy of malignant gliomas. Sem. Oncol., 1994. 21: p. 249-259. 
1 4 . Fine, H., et al., Meta-analysis of radiation therapy with and without adjuvant 
chemotherapy for malignant gliomas in adults. Cancer, 1993. 71: p. 2585-97. 
15. Ausman, J.I., et al., Brain-tumor chemotherapy. Pharmacological principles derived from a 
monkey brain-tumor model. J. Neurosurg., 1977. 46(2): p. 155-64. 
16. Neuwelt, E.A., et al., Therapeutic efficacy of multiagent chemotherapy with drug delivery 
enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery, 1986. 19(4): p. 
573-582. 
17. Brem, H., M.S.J. Mahaley, and N.A. Vick, Interstitial chemotherapy with drug polymer implants 
for the treatment of recurrent gliomas. J. Neurosurg., 1991. 74: p. 441-446. 
Recombinant DNA Research, Volume 20 
[371] 
